ロード中...

Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change

BACKGROUND: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) was developed for use in clinical trials and longitudinal patient assessment. OBJECTIVES: To characterize disease severity using the CDASI and assess responsiveness of this instrument to clinically meaningful changes i...

詳細記述

保存先:
書誌詳細
出版年:Br J Dermatol
主要な著者: Anyanwu, C.O., Fiorentino, D., Chung, L., Dzuong, C., Wang, Y., Okawa, J., Carr, K., Propert, K.J., Werth, V.P.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878996/
https://ncbi.nlm.nih.gov/pubmed/25994337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.13915
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!